571-585 of 825
CDC - Reducing Severe Traumatic Brain Injury in the US, Part 1
Grand Rounds Nation®CDC - Reducing Severe Traumatic Brain Injury in the US, Part 1
Matt Birnholz, MD
Spotlight on Meningiomas: Risks and Clinical Manifestations
NeuroFrontiersSpotlight on Meningiomas: Risks and Clinical Manifestations
Anthony Alessi, MD
Lynn Taylor, MD
Anthony Alessi, MD
Jeffrey Kutcher, MD, FAAN
Treating Diabetic Nerve Pain: Guidelines from the American Academy of Neurology
NeuroFrontiersTreating Diabetic Nerve Pain: Guidelines from the American Academy of Neurology
Anthony Alessi, MD
Vera Bril, MD
How Smart Phones Are Improving Neurologic Care
NeuroFrontiersHow Smart Phones Are Improving Neurologic Care
Anthony Alessi, MD
Neil Busis, MD
The Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease
NeuroFrontiersThe Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease
Anthony Alessi, MD
Lisa Shulman
- advertisement
Neurosurgical Quality Improvement Measures & Patients With Degenerative Disc Disease
Medical Breakthroughs from Penn MedicineNeurosurgical Quality Improvement Measures & Patients With Degenerative Disc Disease
Lee Freedman, MD
Neil Malhotra, MD
Endoscopic Brain Surgery, In 3-D
Medical Breakthroughs from Penn MedicineEndoscopic Brain Surgery, In 3-D
Lee Freedman, MD
John Y.K. Lee, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Matt Birnholz, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
Matt Birnholz, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
Matt Birnholz, MD
Focusing on Comfort in Caring for Patients with Dementia and Alzheimer's
Advances in Long Term Care MedicineFocusing on Comfort in Caring for Patients with Dementia and Alzheimer's
Eric Tangalos, MD
Tena Alonzo, MA
- advertisement
How to Help Patients Cope With Loss of Taste and Smell
NeuroFrontiersHow to Help Patients Cope With Loss of Taste and Smell
Anthony Alessi, MD
Ronald DeVere, MD
Emerging New Therapies for Multiple Sclerosis Patients
NeuroFrontiersEmerging New Therapies for Multiple Sclerosis Patients
Anthony Alessi, MD
Jeffrey Cohen, MD
Updated Guidelines for Brain Death and the Impact on Organ Donation
NeuroFrontiersUpdated Guidelines for Brain Death and the Impact on Organ Donation
Anthony Alessi, MD
Eelco Wijdicks, MD, PhD
